These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1541142)

  • 1. Chest roentgenographic abnormalities in IL-2 recipients. Incidence and correlation with clinical parameters.
    Vogelzang PJ; Bloom SM; Mier JW; Atkins MB
    Chest; 1992 Mar; 101(3):746-52. PubMed ID: 1541142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular leak syndrome associated with interleukin-2: chest radiographic manifestations.
    Mann H; Ward JH; Samlowski WE
    Radiology; 1990 Jul; 176(1):191-4. PubMed ID: 2353090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between development of pulmonary edema and response of pulmonary metastases of metastatic melanoma and kidney cancer to high-dose continuous-infusion interleukin-2.
    Quan WD; Khan N; Ramirez M; Taylor WC; Quan F; Vinogradov M; Walker P
    Cancer Biother Radiopharm; 2005 Apr; 20(2):151-4. PubMed ID: 15869448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of pulmonary edema during interleukin-2 therapy: correlation of chest radiographic and clinical findings in 54 patients.
    Saxon RR; Klein JS; Bar MH; Blanc P; Gamsu G; Webb WR; Aronson FR
    AJR Am J Roentgenol; 1991 Feb; 156(2):281-5. PubMed ID: 1898799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized phase II trial of continuous infusion interleukin-2 or bolus injection interleukin-2 plus lymphokine-activated killer cells for advanced renal cell carcinoma.
    Weiss GR; Margolin KA; Aronson FR; Sznol M; Atkins MB; Dutcher JP; Gaynor ER; Boldt DH; Doroshow JH; Bar MH
    J Clin Oncol; 1992 Feb; 10(2):275-81. PubMed ID: 1732429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary toxicity of recombinant interleukin-2 plus lymphokine-activated killer cell therapy.
    Villani F; Galimberti M; Rizzi M; Manzi R
    Eur Respir J; 1993 Jun; 6(6):828-33. PubMed ID: 8339802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiologic characteristics of the thorax during therapy with interleukin-2].
    Morassut S; Balestreri L; Galligioni E; Coran F; Sacco C
    Radiol Med; 1992 Oct; 84(4):368-71. PubMed ID: 1455017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged continuous intravenous infusion interleukin-2 and lymphokine-activated killer-cell therapy for metastatic renal cell carcinoma.
    Thompson JA; Shulman KL; Benyunes MC; Lindgren CG; Collins C; Lange PH; Bush WH; Benz LA; Fefer A
    J Clin Oncol; 1992 Jun; 10(6):960-8. PubMed ID: 1588376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase Ib trial of pentoxifylline and ciprofloxacin in patients treated with interleukin-2 and lymphokine-activated killer cell therapy for metastatic renal cell carcinoma.
    Thompson JA; Bianco JA; Benyunes MC; Neubauer MA; Slattery JT; Fefer A
    Cancer Res; 1994 Jul; 54(13):3436-41. PubMed ID: 8012963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 2 and lymphokine-activated killer cell therapy: analysis of a bolus interleukin 2 and a continuous infusion interleukin 2 regimen.
    Clark JW; Smith JW; Steis RG; Urba WJ; Crum E; Miller R; McKnight J; Beman J; Stevenson HC; Creekmore S
    Cancer Res; 1990 Nov; 50(22):7343-50. PubMed ID: 2224862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiorespiratory effects of immunotherapy with interleukin-2.
    Lee RE; Lotze MT; Skibber JM; Tucker E; Bonow RO; Ognibene FP; Carrasquillo JA; Shelhamer JH; Parrillo JE; Rosenberg SA
    J Clin Oncol; 1989 Jan; 7(1):7-20. PubMed ID: 2783338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of intraperitoneal recombinant interleukin-2/lymphokine-activated killer cells in patients with ovarian cancer.
    Stewart JA; Belinson JL; Moore AL; Dorighi JA; Grant BW; Haugh LD; Roberts JD; Albertini RJ; Branda RF
    Cancer Res; 1990 Oct; 50(19):6302-10. PubMed ID: 2205379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of human leukocyte antigen-mismatched allogeneic lymphokine-activated killer cells and interleukin-2 in the adoptive immunotherapy of patients with malignancies.
    Kimoto Y
    Hum Cell; 1992 Sep; 5(3):226-35. PubMed ID: 1467321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal reexpansion pulmonary edema after drainage of large pleural effusions: clinical evidence suggesting hypoxic injury to the lung as the cause of edema.
    Woodring JH
    South Med J; 1997 Dec; 90(12):1176-82. PubMed ID: 9404901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary complications in fulminant hepatic failure: analysis of serial radiographs from 100 consecutive patients.
    Warren R; Trewby PN; Laws JW; Williams R
    Clin Radiol; 1978 Jul; 29(4):363-9. PubMed ID: 679608
    [No Abstract]   [Full Text] [Related]  

  • 16. Interleukin-2 therapy for advanced renal cell carcinoma: radiographic evaluation of response and complications.
    Davis SD; Berkmen YM; Wang JC
    Radiology; 1990 Oct; 177(1):127-31. PubMed ID: 2399311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local adoptive immunotherapy using lymphokine-activated killer cells and interleukin-2 against malignant pleural mesothelioma: report of two cases.
    Yanagawa H; Sone S; Fukuta K; Nishioka Y; Ogura T
    Jpn J Clin Oncol; 1991 Oct; 21(5):377-83. PubMed ID: 1753419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphokine-activated killer (LAK) therapy for metastatic renal cell carcinoma].
    Nakano E
    Hinyokika Kiyo; 1992 Nov; 38(11):1305-9. PubMed ID: 1485586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Black, white, and shades of gray: common abnormalities in chest radiographs.
    Connolly MA
    AACN Clin Issues; 2001 May; 12(2):259-69; quiz 330-2. PubMed ID: 11759553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intrapleural administration of LAK cells combined with rIL2 in the treatment of advanced lung cancer with malignant pleural effusion].
    Mao G; Gao Z; Wang Q
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr; 18(2):83-4, 127. PubMed ID: 7553956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.